[go: up one dir, main page]

AR111884A1 - COMPOSITIONS THAT INCLUDE BACTERIAL BREEDS OF GENRE BLAUTIA - Google Patents

COMPOSITIONS THAT INCLUDE BACTERIAL BREEDS OF GENRE BLAUTIA

Info

Publication number
AR111884A1
AR111884A1 ARP180101358A ARP180101358A AR111884A1 AR 111884 A1 AR111884 A1 AR 111884A1 AR P180101358 A ARP180101358 A AR P180101358A AR P180101358 A ARP180101358 A AR P180101358A AR 111884 A1 AR111884 A1 AR 111884A1
Authority
AR
Argentina
Prior art keywords
blautia
breeds
genre
compositions
include bacterial
Prior art date
Application number
ARP180101358A
Other languages
Spanish (es)
Inventor
Alexander James Stevenson
Imke Elisabeth MULDER
Helene M Savignac
Original Assignee
4D Pharma Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4D Pharma Res Ltd filed Critical 4D Pharma Res Ltd
Publication of AR111884A1 publication Critical patent/AR111884A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Reivindicación 1: Una composición que comprende una cepa bacteriana del género Blautia, para el uso en un método de tratamiento de lesión cerebral. Reivindicación 28: Un producto alimenticio que comprende la composición de cualquier reivindicación anterior, para el uso de cualquier reivindicación anterior. Reivindicación 29: Una composición de vacuna que comprende la composición de cualquier reivindicación anterior, para el uso de cualquier reivindicación anterior.Claim 1: A composition comprising a bacterial strain of the genus Blautia, for use in a method of treating brain injury. Claim 28: A food product comprising the composition of any preceding claim, for the use of any preceding claim. Claim 29: A vaccine composition comprising the composition of any preceding claim, for the use of any preceding claim.

ARP180101358A 2017-05-22 2018-05-22 COMPOSITIONS THAT INCLUDE BACTERIAL BREEDS OF GENRE BLAUTIA AR111884A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1708176.1A GB201708176D0 (en) 2017-05-22 2017-05-22 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
AR111884A1 true AR111884A1 (en) 2019-08-28

Family

ID=59220630

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP180101357A AR111883A1 (en) 2017-05-22 2018-05-22 COMPOSITIONS THAT INCLUDE BACTERIAL BLAUTIA VINETS
ARP180101358A AR111884A1 (en) 2017-05-22 2018-05-22 COMPOSITIONS THAT INCLUDE BACTERIAL BREEDS OF GENRE BLAUTIA
ARP180101360A AR111822A1 (en) 2017-05-22 2018-05-23 COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP180101357A AR111883A1 (en) 2017-05-22 2018-05-22 COMPOSITIONS THAT INCLUDE BACTERIAL BLAUTIA VINETS

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP180101360A AR111822A1 (en) 2017-05-22 2018-05-23 COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES

Country Status (2)

Country Link
AR (3) AR111883A1 (en)
GB (1) GB201708176D0 (en)

Also Published As

Publication number Publication date
AR111822A1 (en) 2019-08-21
GB201708176D0 (en) 2017-07-05
AR111883A1 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
AR110684A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES AND TREATMENT METHOD
CL2019002640A1 (en) Proprietary molecules to reduce virulence of pathogens.
MX2018004715A (en) Composition comprising a mixture of molecules extracted from chrysanthellum indicum, cynara scolymus and lycium barbarum and use to act on carbohydrate and/or fat metabolism.
CL2017000437A1 (en) Composition that contains a mixture of plant extract or a mixture of molecules contained in said plants, and its use to control the metabolism of lipids or carbohydrates
WO2016033439A3 (en) Compositions and methods for the treating an inflammatory disease or disorder
MX394909B (en) Use of pasteurized akkermansia for treating metabolic disorders
MX2016014102A (en) Compositions and methods for modulating angiopoietin-like 3 expression.
PH12017500746A1 (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
MX386086B (en) Cannabis composition
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
EP3536168A3 (en) Probiotic formulations and methods for use
CR20170009A (en) Compositions and Methods for Packaging Products
MX2018002543A (en) Compositions comprising urolithin compounds.
CL2021003291A1 (en) Mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases.
MY208313A (en) Compositions and methods for treating brain injury
MX421726B (en) Extruded corn protein material
MX392182B (en) FIXED-DOSE COMBINATIONS AND FORMULATIONS COMPRISING 8-HYDROXY-2,2,14,14 TETRAMETHYLPENTADECANEDIOIC ACID (ETC1002) AND EZETIMIBE AND METHODS FOR TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE.
MX379201B (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018004796A (en) Preservation of water-soluble vitamins.
WO2018097712A8 (en) Method for preparing a carbohydrate and/or protein product
WO2016080796A3 (en) Pharmaceutical composition, containing sesquiterpene compound, for preventing or treating stat3-mediated diseases, and use thereof
MX2017007000A (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same.
WO2017079403A3 (en) Polymeric nanoparticles
CO2018004582A2 (en) Poultry foods and, in particular, poultry foods, comprising synthetic derivatives of capsaicinoids and such foods for prophylactic use or treatment of salmonella infection
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.

Legal Events

Date Code Title Description
FB Suspension of granting procedure